Fosamax Lawsuits' Future to be Decided by Supreme Court
More Info: Defective Drugs
The fate of about 500 lawsuits involving the drug Fosamax is now in the hands of the U.S. Supreme Court.
The nation’s highest court has agreed to consider overturning an appellate court ruling that reinstated the lawsuits after a federal trial judge dismissed them.
The issue involves whether Merck, the manufacturer of the osteoporosis drug, failed to warn of the danger that patients taking Fosamax could develop a specific type of thigh bone fractures.
Merck argues that it asked the U.S. Food and Drug Administration to approve such a warning on its label, but the FDA denied its request.
Lawyers for the injured patients say Merck asked for a warning about a different kind of fracture than those involved in the lawsuits.
The Third Circuit Court of Appeals ruled in March 2017 that jurors should decide the issue. But the Trump administration — invited by the Supreme Court to weigh in — maintained this issue should be decided by judges.
See the original article here: https://www.drugwatch.com/news/2018/07/02/fosamax-lawsuits-future-to-be-decided-by-supreme-court/
About TriMark Legal Funding
TriMark Legal Funding was founded in 2003 and is one of America's leading national lawsuit funding companies. TriMark provides pre-settlement funding and post-settlement funding, sometimes called 'lawsuit loans', to injured plaintiffs throughout the United States. We offer funding on hundreds of different types of legal claims including personal injury loans, employment litigation funding, work injury accident loans, workers compensation loans, mass tort litigation funding, and multidistrict litigation funding.
We also provide immediate inheritance advance funding for heirs and beneficiaries, as well as attorney funding and law firm financing for legal practices.
|Personal Injury Lawsuits||Mass Torts|
Click here to see the original article.